Ethyl 5-carbamoyl-1-methyl-1H-pyrazole-4-carboxylate, 95.0%, 250mg

6-Chloro-5-methyl-1-(tetrahydro-2H-pyran-2-yl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indazole, 98%, 100mg

2,2'-(1-Methylpiperidine-4,4-diyl)diacetic acid, 98%, 250mg

Ethyl 1-Cyclopropyl-6,7-difluoro-4-oxo-1,4-dihydroquinoline-3-carboxylate>98.0%(GC)1g

Diisobutyl nonanedioate, 95.0%, 1g

2-Bromo-4-fluoro-6-methylaniline, 95.0%, 10g

Triclorometano/cloroformo D1, 99,8 at%D, stab. con Ag, 25 ml, envase de vidrio

4,6-Dichloro-N-methoxy-N-methyl-pyridine-3-carboxamide, 98+%, 1g

(2S,3S)-3-Hydroxy-2-(4-methoxyphenyl)-2,3-dihydrobenzo[b][1,4]thiazepin-4(5H)-one, 95.0%, 100g

4-Bromo-7-nitro-1H-indazole, 95.0%, 10g

(R)-4-Benzyl-5-hydroxymethylmorpholin-3-one, 98.0%, 5g

1-Chloro-4-(ethylthio)benzene, 5g

1-Phenylprop-2-en-1-one (Stabilized with 0.1% hydroquinone), 95.0%, 1g